By targeting proteins used to splice genes, UC San Diego researchers have unlocked a new approach to treating triple-negative ...
Significantly longer progression-free survival seen among patients with previously untreated, PD-L1 advanced or metastatic ...
Health and Me on MSN
Scientists unveil powerful antibody against deadliest breast cancer
Medical University of South Carolina researchers have now developed an antibody that can help fight against triple-negative ...
A new preclinical study from researchers at The University of Texas MD Anderson Cancer Center, published in Nature ...
In a TNBC animal model with limited responsiveness to chemotherapy, Telomir-1 demonstrated statistically significant activity on both tumor growth and cancer cell spread.
🎥 Video Details 🎥 🌟 About This Video 🌟 Cleveland Clinic released December phase-one results for a preventive breast ...
Of all the types of breast cancer, triple negative breast cancer (TNBC) is the most aggressive and lacks specific therapies.
Researchers developed a liquid biopsy method that improved detection of live circulating tumor cells in triple negative ...
ITI-5000 utilizes nucleic acid vaccine constructs engineered to preferentially deliver tumor-associated antigens (TAAs) to the MHC II compartment via LAMP-1, potentially enhancing antigen presentation ...
Scientists have developed a blood test that can help predict which breast cancer treatment will work best. The team at the ...
Immunomic Therapeutics, Inc. ("ITI"), a privately held clinical-stage biotechnology company pioneering nucleic acid-based immunotherapy, today announced that the U.S. Food and Drug Administration (FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results